Fax: (011) 0039-0972726217
In search of combinations for the treatment of patients with high-risk acute myeloid leukemia
Version of Record online: 8 SEP 2008
Copyright © 2008 American Cancer Society
Volume 113, Issue 8, pages 1995–1998, 15 October 2008
How to Cite
Musto, P. and Ferrara, F. (2008), Clofarabine. Cancer, 113: 1995–1998. doi: 10.1002/cncr.23804
See referenced original article on pages 2090–6, this issue.
- Issue online: 3 OCT 2008
- Version of Record online: 8 SEP 2008
- Manuscript Accepted: 15 MAY 2008
- Manuscript Revised: 14 APR 2008
- Manuscript Received: 14 FEB 2008
Although relapse still represents the most relevant obstacle to achieving a cure in acute myeloid leukemia, it offers an opportunity to investigate new therapeutic strategies, mainly in patients who are expected to gain negligible advantage from conventional salvage chemotherapy. In this setting, clofarabine represents 1 of the most promising drugs.